Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
American Journal of Respiratory and Critical Care Medicine|September 3, 2014
Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosisMike O Becker, Angela Kill, Marissa Kutsche, et al.
Scientific Reports|September 28, 2020
Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasisLucy Kappes, Ruba L Amer, Sabine Sommerlatte, et al.
Frontiers in Immunology|October 14, 2022
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severityFranziska Sotzny, Igor Salerno Filgueiras, Claudia Kedor, et al.
European Heart Journal|November 9, 2023
Autoantibodies against the chemokine receptor 3 predict cardiovascular riskFelix S Müller, Zouhair Aherrahrou, Hanna Grasshoff, et al.
ERJ Open Research|December 28, 2022
Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19Florian Tran, Danielle M M Harris, Alena Scharmacher, et al.
Kidney International|August 28, 2024
Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN)Valentin Goutaudier, Richard Danger, Rusan Ali Catar, et al.
Npj Aging|August 24, 2023
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approachDennyson Leandro M Fonseca, Igor Salerno Filgueiras, Alexandre H C Marques, et al.
Nature Communications|December 8, 2018
GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasisOtavio Cabral-Marques, Alexandre Marques, Lasse Melvær Giil, et al.
Journal of Medical Virology|February 1, 2023
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severityGabriela C Baiocchi, Aristo Vojdani, Avi Z Rosenberg, et al.
Pageof 11